Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies. Present-day treatments have not shown real improvements in reducing the high mortality rate and the short survival of the disease. The average survival is less than 5% after 5 years. New innovative treatments are necessary...

Descripción completa

Detalles Bibliográficos
Autores principales: Koltai, Tomas, Reshkin, Stephan Joel, Carvalho, Tiago M. A., Cardone, Rosa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069142/
https://www.ncbi.nlm.nih.gov/pubmed/33921242
http://dx.doi.org/10.3390/ijms22083953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069142/
https://www.ncbi.nlm.nih.gov/pubmed/33921242
http://dx.doi.org/10.3390/ijms22083953

Ejemplares similares